6. Interstitial Lung Disease
Definition
ILD is a group of chronic lung disorders causing inflammation and fibrosis of the lung interstitium, leading to progressive breathlessness and impaired gas exchange.
🔬Pathophysiology
🧠 Mnemonic: FIBROSE
Fibrosis of alveolar interstitium
Inflammatory infiltrate (T-cells, macrophages)
Basal and subpleural predominance
Restrictive pattern (↓TLC, FVC, DLCO)
Over time → honeycombing, traction bronchiectasis
Stiff lung = reduced compliance
End-stage: pulmonary hypertension + respiratory failure
Causes of ILD
Mnemonic: LUNG SCAR
Lung disease (TB, pneumonia, COVID pneumonitis)
Unknown (Idiopathic Pulmonary Fibrosis – IPF)
Neoplasm/radiation
Gastro-oesophageal reflux (microaspiration)
Sarcoidosis
Connective tissue disease (RA, SLE, systemic sclerosis)
Asbestos / occupational (coal, silica, hypersensitivity pneumonitis)
Reaction to drugs (amiodarone, methotrexate, nitrofurantoin)
Clinical Features
Mnemonic: DRY AIR
Dry cough
Restrictive dyspnoea (progressive)
Yearning for air (breathless on exertion)
Associated clubbing
Inspiratory fine crackles (velcro-like)
Refractory to treatment (especially IPF)
Physical Examination Findings
Bibasal fine end-inspiratory crackles
Finger clubbing
Signs of pulmonary hypertension in late disease
May have features of connective tissue disorder (joint pain, rash, Raynaud’s)
🔎Investigations
🧠 Mnemonic: BLOOM CT
Bloods – ANA, RF, ENA, ANCA (connective tissue screen)
Lung function tests (↓FVC, ↓DLCO, normal/↑FEV1:FVC)
Oxygen saturation (desaturation on exertion)
Open lung biopsy (rare – if diagnosis unclear)
Microbiology (rule out infection)
CT Chest (HRCT = gold standard: shows honeycombing, reticulation, traction bronchiectasis)
Testing for causative agents (occupational exposure, drugs, autoimmune)
Management
Mnemonic: FIBROSIS PLAN
-
Fibrosis reversal limited – focus on slowing progression
-
Immunosuppressants (e.g. steroids in CTD-related ILD)
-
Breathing support (LTOT if hypoxic)
-
Referral to ILD specialist centre early
-
Oxygen for ambulatory desaturation
-
Symptom relief (opiates for breathlessness, psychological support)
-
Infection prevention: vaccinations
-
Stop causative drug/exposure
-
Pirfenidone or nintedanib for IPF
-
Lung transplant in eligible advanced cases
-
Alveolar rehabilitation
-
Non-invasive ventilation in end-stage
⚠️ Complications
Respiratory failure
Pulmonary hypertension
Cor pulmonale
Acute exacerbations
Increased risk of lung cancer
Depression / reduced QoL
🧐 Differentials
🧠 Mnemonic: CHRONIC
COPD (more obstructive)
Heart failure (fluid overload crackles)
RA-associated bronchiolitis
Overweight-related dyspnoea
Neoplasm (central obstruction)
Infection (esp. post-COVID fibrosis)
Connective tissue mimics (sarcoid, vasculitis)
📌 PARA Revision Tips
HRCT is gold standard: know typical vs atypical pattern
Dry cough + basal crackles + ↓DLCO = think ILD
Antifibrotics only approved for IPF
Clubbing, crackles, and restrictive spirometry = classic triad
Always check occupational and drug history
🔎 Last updated in line with NICE NG163 and BTS/NHS England ILD service specifications
Published: March 2020 • Last updated: May 2023
Last reviewed: July 2025
🔒 PASSMAP ensures all content is NICE-aligned and reviewed for Physician Associate Registration Assessment (PARA) success.
